» CRYOcheck™ Factor VII Deficient Plasma

ROUTINE FROZEN IMMUNODEPLETED DEFICIENT PLASMAS EXTRINSIC PATHWAY

CRYOcheck™ Factor VII Deficient Plasma

Fresh frozen plasmas

Plasma deficient for Factor VII assay.

CRYOcheck™Factor VII Deficient is a frozen plasma, immuno-depleted, poor in platelets and certified to have less than 1% Factor VII.
It is deficient both for antigenic assay and functional in hemostasis.

Your opinion on this product ?

Reference	Presentation	Packaging	Number of tests
FDP07-10	Kit	25 x 1.0 mL	500
FDP07-15	Kit	25 x 1.5 mL	750

The Safety Data Sheets and Notices are accessible to our registered customers.

Factor VII (FVII) is a glycoprotein synthesized by the liver, vitamin k dependent. When tissue factor (TF) appears on the surface of damaged, abnormal or activated vascular endothelium, FVIIa associates with it, initiating the extrinsic pathway of coagulation.
The FT-FVIIa complex activates the FX in FXa and the FIX in FIXa.

CRYOcheck™Factor Deficient Plasma consist of pools of citrated human normal plasmas which have been depleted into a coagulation factor by immunoadsorption, buffered with HEPES buffer, aliquoted and frozen rapidly.

- Certificate of analysis supplied with each batch.
- Expiration date of 3 years from the date of manufacture with storage between -40 ° C and -80 °C

- CE adaptation on many analyzers on the market
- Technical validation file
- Reserved lots
- Ready to use

- 25 cryotubes x 1 mL or 1.5 mL of frozen plasma

CRYOcheck™ Abnormal 1 Reference Control
CRYOcheck™ Abnormal 2 Reference Control
CRYOcheck™ Normal Reference Plasma
CRYOcheck™ Reference Control Normal

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.

ROUTINE FROZEN IMMUNODEPLETED DEFICIENT PLASMAS EXTRINSIC PATHWAY

CRYOcheck™ Factor VII Deficient Plasma

Fresh frozen plasmas

Your opinion on this product ?

The Safety Data Sheets and Notices are accessible to our registered customers.

Cryopep Thrombosis Haemostasis Catalogue 2022

Cryopep Haemostasis Research Catalogue 2022

Product List Precision Biologic

Cryocheck Factor Deficient Plasmas

You must identify yourself to search for a certificate of analysis

ROUTINE FROZEN IMMUNODEPLETED DEFICIENT PLASMAS EXTRINSIC PATHWAY

CRYOcheck™ Factor VII Deficient Plasma

Fresh frozen plasmas

Download the catalog brochure

Your opinion on this product ?

The Safety Data Sheets and Notices are accessible to our registered customers.

Cryopep Thrombosis Haemostasis Catalogue 2022

Cryopep Haemostasis Research Catalogue 2022

Product List Precision Biologic

Cryocheck Factor Deficient Plasmas